Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid
NCT02398266 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2017-06-19
Summary
The measurement of limb skeletal muscle perfusion and perfusion reserve during exercise is an approach that can assess the total impact of the complex pathophysiologic processes in patients with limb ischemia, particularly in those with diabetes in whom distal arterial disease and abnormal microvascular functional responses are common. This trial is designed to: (a) optimize methods for assessment of limb perfusion at rest and during stress using contrast-enhanced ultrasound (normal subjects) and a microbubble contrast agent that is able to provide non-linear signal without destruction at medium acoustic pressures, and (b) to test whether perfusion imaging provides incremental information on the severity of disease in patients with peripheral artery disease.
Conditions
Interventions
- DRUG
-
Contrast ultrasound of leg muscle with Sonazoid (Contrast ultrasound microvascular perfusion imaging)
Skeletal muscle perfusion assessment of the thigh and calf skeletal muscle will be performed with contrast ultrasound of leg muscle with Sonazoid while at rest and during exercise stress
Sponsors & Collaborators
-
Oregon Health and Science University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-01
- Primary Completion
- 2018-07-01
- Completion
- 2018-07-01
Countries
- United States
Study Locations
More Related Trials
-
Safety and Feasibility Study of the Shockwave Lithoplasty System
NCT01577888 ·Status: COMPLETED ·Phase: NA
-
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
NCT03358355 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
NCT03318484 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.
NCT00720577 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
STEPUP Clinical Trial
NCT05445375 ·Status: COMPLETED ·Phase: NA
-
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
NCT02956993 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
NCT03297814 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease
NCT02636283 ·Status: TERMINATED ·Phase: PHASE2
-
Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication
NCT01890135 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD
NCT01785524 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis
NCT02941419 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
L-Arginine in the Treatment of Peripheral Arterial Disease
NCT00284076 ·Status: COMPLETED ·Phase: NA
-
Selective Coronary Revascularization in Peripheral Artery Disease Patients (SCOREPAD Trial)
NCT06250790 ·Status: RECRUITING
-
A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
NCT02506062 ·Status: COMPLETED ·Phase: NA
-
Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System
NCT04585763 ·Status: COMPLETED ·Phase: NA
-
Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
NCT00155350 ·Status: UNKNOWN ·Phase: PHASE4
-
Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)
NCT02369848 ·Status: COMPLETED ·Phase: NA
-
Evaluation of MST-188 in Acute Lower Limb Ischemia
NCT02093468 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
NCT01174056 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
TRACER RGD-K5 Carotid Plaque Imaging Study
NCT01968226 ·Status: TERMINATED ·Phase: PHASE2
-
ARREST PAD (Peripheral Arterial Disease)
NCT00153166 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
NCT07223593 ·Status: RECRUITING ·Phase: PHASE3
-
NAD Supplementation and Vascular Health in PAD
NCT06534944 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques
NCT03382249 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
NCT00059644 ·Status: TERMINATED ·Phase: PHASE3